References
1. Pritz T, Weinberger B, Grubeck-Loebenstein B. The aging bone marrow
and its impact on immune responses in old age. Immunol Lett 2014;162 :310-5.
2. Pangrazzi L, Meryk A, Naismith E, et al. ”Inflamm-aging” influences
immune cell survival factors in human bone marrow. Eur J Immunol
2017; 47 :481-92.
3. Pawelec G. Hallmarks of human ”immunosenescence”: adaptation or
dysregulation? Immun Ageing 2012; 9 :15.
4. Peters A, Delhey K, Nakagawa S, et al. Immunosenescence in wild
animals: meta-analysis and outlook. Ecol Lett 2019;22 :1709-22.
5. Yao WL, Wen Q, Zhao HY, et al. Different subsets of haematopoietic
cells and immune cells in bone marrow between young and older
donors. Clin Exp Immunol 2021; 203 :137-49.
6. Pang WW, Price EA, Sahoo D, et al. Human bone marrow hematopoietic
stem cells are increased in frequency and myeloid-biased with
age. Proc Natl Acad Sci U S A 2011; 108 :20012-7.
7. Lynch HE, Goldberg GL, Chidgey A, et al. Thymic involution and immune
reconstitution. Trends Immunol 2009; 30 :366-73.
8. George AJ, Ritter MA. Thymic involution with ageing: obsolescence or
good housekeeping? Immunol Today 1996; 17 :267-72.
9. Riether C, Schürch CM, Ochsenbein AF. Regulation of hematopoietic and
leukemic stem cells by the immune system. Cell Death Differ 2015;22 :187-98.
10. Naserian S, Abdelgawad ME, Afshar Bakshloo M, et al. The TNF/TNFR2
signaling pathway is a key regulatory factor in endothelial progenitor
cell immunosuppressive effect. Cell Commun Signal 2020;18 :94.
11. Crane GM, Jeffery E, Morrison SJ. Adult haematopoietic stem cell
niches. Nat Rev Immunol 2017; 17 :573-90.
12. Poulos MG, Ramalingam P, Gutkin MC, et al. Endothelial
transplantation rejuvenates aged hematopoietic stem cell
function. J Clin Invest 2017; 127 :4163-78.
13. Hooper AT, Butler JM, Nolan DJ, et al. Engraftment and
reconstitution of hematopoiesis is dependent on VEGFR2-mediated
regeneration of sinusoidal endothelial cells. Cell Stem Cell
2009; 4 :263-74.
14. Razakandrainibe R, Pelleau S, Grau GE, et al. Antigen presentation
by endothelial cells: what role in the pathophysiology of malaria?
Trends Parasitol 2012; 28 :151-60.
15. Lim WC, Olding M, Healy E, et al. Human Endothelial Cells Modulate
CD4(+) T Cell Populations and Enhance Regulatory T Cell Suppressive
Capacity. Front Immunol 2018; 9 :565.
16. Khayyamian S, Hutloff A, Buchner K, et al. ICOS-ligand, expressed on
human endothelial cells, costimulates Th1 and Th2 cytokine secretion by
memory CD4+ T cells. Proc Natl Acad Sci U S A 2002;99 :6198-203.
17. Liu J, Jiang M, Ma Z, et al. TLR1/2 ligand-stimulated mouse liver
endothelial cells secrete IL-12 and trigger CD8+ T cell immunity in
vitro. J Immunol 2013; 191 :6178-90.
18. Khakpour S, Wilhelmsen K, Hellman J. Vascular endothelial cell
Toll-like receptor pathways in sepsis. Innate Immun 2015;21 :827-46.
19. Hancock WW, Sayegh MH, Zheng XG, et al. Costimulatory function and
expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac
allograft rejection. Proc Natl Acad Sci U S A 1996;93 :13967-72.
20. Lozanoska-Ochser B, Klein NJ, Huang GC, et al. Expression of CD86 on
human islet endothelial cells facilitates T cell adhesion and
migration. J Immunol 2008; 181 :6109-16.
21. Diehl L, Schurich A, Grochtmann R, et al. Tolerogenic maturation of
liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+
T cell tolerance. Hepatology 2008; 47 :296-305.
22. Limmer A, Ohl J, Kurts C, et al. Efficient presentation of exogenous
antigen by liver endothelial cells to CD8+ T cells results in
antigen-specific T-cell tolerance. Nat Med 2000;6 :1348-54.
23. Cao XN, Kong Y, Song Y, et al. Impairment of bone marrow endothelial
progenitor cells in acute graft-versus-host disease patients after
allotransplant. Br J Haematol 2018; 182 :870-86.
24. Kong Y, Cao XN, Zhang XH, et al. Atorvastatin enhances bone marrow
endothelial cell function in corticosteroid-resistant immune
thrombocytopenia patients. Blood 2018; 131 :1219-33.
25. Kong Y, Shi MM, Zhang YY, et al. N-acetyl-L-cysteine improves bone
marrow endothelial progenitor cells in prolonged isolated
thrombocytopenia patients post allogeneic hematopoietic stem cell
transplantation. Am J Hematol 2018; 93 :931-42.
26. Kong Y, Wang Y, Zhang YY, et al. Prophylactic oral NAC reduced poor
hematopoietic reconstitution by improving endothelial cells after
haploidentical transplantation. Blood Adv 2019;3 :1303-17.
27. Lyu ZS, Cao XN, Wen Q, et al. Autophagy in endothelial cells
regulates their haematopoiesis-supporting ability. EBioMedicine
2020; 53 :102677.
28. Kong Y, Wang YT, Cao XN, et al. Aberrant T cell responses in the
bone marrow microenvironment of patients with poor graft function after
allogeneic hematopoietic stem cell transplantation. J Transl Med
2017; 15 :57.
29. Song Y, Wang YT, Huang XJ, et al. Abnormalities of the bone marrow
immune microenvironment in patients with immune thrombocytopenia.Ann Hematol 2016; 95 :959-65.
30. Wang YT, Kong Y, Song Y, et al. Increased Type 1 Immune Response in
the Bone Marrow Immune Microenvironment of Patients with Poor Graft
Function after Allogeneic Hematopoietic Stem Cell
Transplantation. Biol Blood Marrow Transplant 2016;22 :1376-82.
31. Song Y, Shi MM, Zhang YY, et al. Abnormalities of the Bone Marrow
Immune Microenvironment in Patients with Prolonged Isolated
Thrombocytopenia after Allogeneic Hematopoietic Stem Cell
Transplantation. Biol Blood Marrow Transplant 2017;23 :906-12.
32. Kong Y, Wu YL, Song Y, et al. Ruxolitinib/nilotinib cotreatment
inhibits leukemia-propagating cells in Philadelphia chromosome-positive
ALL. J Transl Med 2017; 15 :184.
33. Kusumbe AP, Ramasamy SK, Itkin T, et al. Age-dependent modulation of
vascular niches for haematopoietic stem cells. Nature 2016;532 :380-4.
34. Heiss C, Keymel S, Niesler U, et al. Impaired progenitor cell
activity in age-related endothelial dysfunction. J Am Coll
Cardiol 2005; 45 :1441-8.
35. Rose ML. Endothelial cells as antigen-presenting cells: role in
human transplant rejection. Cell Mol Life Sci 1998;54 :965-78.
36. Dunzendorfer S, Lee HK, Soldau K, et al. Toll-like receptor 4
functions intracellularly in human coronary artery endothelial cells:
roles of LBP and sCD14 in mediating LPS responses. Faseb j 2004;18 :1117-9.
37. Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease
biology and therapy. Nat Rev Immunol 2012; 12 :443-58.
38. Chang YJ, Zhao XY, Huang XJ. Strategies for Enhancing and Preserving
Anti-leukemia Effects Without Aggravating Graft-Versus-Host
Disease. Front Immunol 2018; 9 :3041.
39. Holtan SG, Pasquini M, Weisdorf DJ. Acute graft-versus-host disease:
a bench-to-bedside update. Blood 2014; 124 :363-73.
40. Zeiser R, Socie G, Blazar BR. Pathogenesis of acute
graft-versus-host disease: from intestinal microbiota alterations to
donor T cell activation. Br J Haematol 2016;175 :191-207.
41. Ferrara JLM, Levine JE, Reddy P, et al. Graft-versus-host
disease. The Lancet 2009; 373 :1550-61.
42. Wang Y, Chang YJ, Xu LP, et al. Who is the best donor for a related
HLA haplotype-mismatched transplant? Blood 2014; 124 :843-50.
43. Chang YJ, Luznik L, Fuchs EJ, et al. How do we choose the best donor
for T-cell-replete, HLA-haploidentical transplantation? J Hematol Oncol
2016; 9 :35.
44. Mir E, Palomo M, Rovira M, et al. Endothelial damage is aggravated
in acute GvHD and could predict its development. Bone Marrow
Transplant 2017; 52 :1317-25.